iPS Cell Heart Repair: World-First Catheter Trial Treats Its First Patient
A Japanese biotech threaded a catheter into a failing heart and delivered iPS-derived muscle without opening the chest. Inside the world's first trial of its kind.
A Japanese biotech threaded a catheter into a failing heart and delivered iPS-derived muscle without opening the chest. Inside the world's first trial of its kind.